| TNF | Tumor necrosis factor |
| TACE | TNF-converting enzyme |
| TNFR2 | TNF receptor type II |
| TNFR1 | TNF receptor type I |
| mTNF | Membrane TNF |
| sTNF | Soluble TNF |
| mTNFR2 | membrane TNFR2 |
| sTNFR2 | Soluble TNFR2 |
| TNFRSF1B | TNF receptor type II |
| TILs | Tumor-infiltrating lymphocytes |
| THD | TNF homology domain |
| CRD | cysteine-rich domain |
| Tregs | Regulatory T cells |
| Teffs | Effector T cells |
| NK | Natural killer |
| IL | Interleukin |
| Th | T Helper Type |
| Foxp3 | Forkhead Box P3 |
| DD | Death domain |
| cIAP | Cellular inhibitor of apoptosis pro ptosis protein |
| FADD | Fas-associated DD |
| VEGFR2 | vascular endothelial growth factor receptor 2 |
| FLICE | for FADD like ICE |
| c-FLIP | Cellular FLICE-like inhibitory protein |
| TRAF | TNFR-associated factor |
| NF-κB | Nuclear factor kappa B |
| MDSCs | Myeloid-derived suppressor cells |
| MAPK | Mitogen-activated protein kinases |
| MSCs | mesenchymal stem cells |
| BAX | BCL2-associated X protein |
| JNK | c-Jun N-terminal kinase |
| PI3K | Phosphoinositide 3-kinase |
| IKKβ | IκB Kinase beta |
| Akt | Protein Kinase B |
| BMX/Etk | bone marrow-expressed kinase |
| NIK | NF-κB-inducing kinase |
| TISIDB | Tumor and Immune System Interaction Database |
| AIP1 | apoptosis signal-regulating kinase 1 (ASK1)-interacting protein-1 |
| BIRC3 | cellular inhibitor of apoptosis 2 |
| GEPIA | Gene Expression Profiling Interactive Analysis |
| NCR1 | Natural cytotoxicity receptor 1 |
| hnRNPK | heterogeneous nuclear ribonuclear protein K |
| YAP | Yes-associated protein |
| MLCK | myosin light-chain kinase |
| NKp46 | natural killer cell p46 |
| STAT | signal transducer and activator of transcription |
| mTOR | Mammalian Target of Rapamycin |
| c-FLIP | Cellular FLICE-like inhibitory protein |
| CTLA-4 | Cytotoxic T Lymphocyte Antigen-4 |
| TGF-β | transforming growth factor-β |
| PD1 | programmed death-1 |
| PDL1 | programmed cell death receptor ligand 1 |
| Ki67 | Tumor proliferation marker |
| LAG3 | Lymphocyte-Activation Gene 3 |
| Fc | Fragment crystallisable |
| VEGF | vascular endothelial growth factor |
| TCGA | The Cancer Genome Atlas |
| C-Jun | transcription factor AP-1-like |
| OS | overall survival |
| MLCK | myosin light-chain kinase |
| DFS | disease-free survival |
| CXCR4 | C-X-C chemokine receptor 4 |
| IFN-γ | interferon-γ |
| CXCL12 | chemokine C-X-C motif ligand 12 |
| p65 | NF-kB subunit |
| CSN5 | constitutive photomorphogenic-9 signalosome |
| ACC | Adrenocortical Carcinoma |
| BLCA | Bladder Urothelial Carcinoma |
| BRCA | Breast invasive carcinoma |
| COAD | Colon adenocarcinoma |
| DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
| CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma |
| CHOL | Cholangiocarcinoma |
| HNSC | Head and Neck squamous cell carcinoma |
| GBM | Glioblastoma multiforme |
| ESCA | Oesophageal carcinoma |
| KICH | Kidney Chromophobe |
| KIRC | Kidney renal clear cell carcinoma |
| KIRP | Kidney renal papillary cell carcinoma |
| LAML/AML | Acute Myeloid Leukaemia |
| LGG | Brain Lower-Grade Glioma |
| LIHC | Liver hepatocellular carcinoma |
| LUAD | Lung adenocarcinoma |
| LUSC | Lung squamous cell carcinoma |
| PAAD | Pancreatic adenocarcinoma |
| OV | Ovarian serous cystadenocarcinoma |
| PRAD | Prostate adenocarcinoma |
| PCPG | Pheochromocytoma and Paraganglioma |
| READ | Rectum adenocarcinoma |
| SARC | Sarcoma |
| SKCM | Skin Cutaneous Melanoma |
| STAD | Stomach adenocarcinoma |
| HLA-G | human leucocyte antigen-G |
| THCA | Thyroid carcinoma |
| THYM | Thymoma |
| UCEC | Uterine Corpus Endometrial Carcinoma |
| UCS | Uterine Carcinosarcoma |
| TNBC | triple-negative breast cancer |
| UVM | Uveal Melanoma |
| AICD | Activation-induced Cell Death |
| EPCs | endothelial progenitor cell |